Citadel Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
166,234
-208,022
| -56% | -$1.43M | ﹤0.01% | 3171 |
|
|
2025
Q1 | $1.08M | Buy |
374,256
+40,933
| +12% | +$118K | ﹤0.01% | 3203 |
|
|
2024
Q4 | $1.57M | Sell |
333,323
-1,015,470
| -75% | -$4.77M | ﹤0.01% | 2848 |
|
|
2024
Q3 | $4.82M | Sell |
1,348,793
-428,319
| -24% | -$1.53M | ﹤0.01% | 1799 |
|
|
2024
Q2 | $11M | Buy |
1,777,112
+451,733
| +34% | +$2.8M | ﹤0.01% | 1166 |
|
|
2024
Q1 | $12.5M | Sell |
1,325,379
-78,494
| -6% | -$741K | ﹤0.01% | 1160 |
|
|
2023
Q4 | $9.48M | Buy |
1,403,873
+149,689
| +12% | +$1.01M | ﹤0.01% | 1263 |
|
|
2023
Q3 | $5.57M | Sell |
1,254,184
-250,455
| -17% | -$1.11M | ﹤0.01% | 1549 |
|
|
2023
Q2 | $4.97M | Buy |
1,504,639
+1,295,180
| +618% | +$4.27M | ﹤0.01% | 1728 |
|
|
2023
Q1 | $597K | Sell |
209,459
-606,785
| -74% | -$1.73M | ﹤0.01% | 3701 |
|
|
2022
Q4 | $5.94M | Buy |
816,244
+174,112
| +27% | +$1.27M | ﹤0.01% | 1650 |
|
|
2022
Q3 | $5.2M | Buy |
642,132
+586,085
| +1,046% | +$4.74M | ﹤0.01% | 1816 |
|
|
2022
Q2 | $275K | Sell |
56,047
-56,156
| -50% | -$276K | ﹤0.01% | 4707 |
|
|
2022
Q1 | $2.65M | Sell |
112,203
-58,758
| -34% | -$1.39M | ﹤0.01% | 2697 |
|
|
2021
Q4 | $3.02M | Sell |
170,961
-142,949
| -46% | -$2.53M | ﹤0.01% | 2606 |
|
|
2021
Q3 | $8.86M | Sell |
313,910
-96,615
| -24% | -$2.73M | ﹤0.01% | 1542 |
|
|
2021
Q2 | $4.3M | Buy |
+410,525
| New | +$4.3M | ﹤0.01% | 2335 |
|